https://www.selleckchem.com/pr....oducts/cx-4945-silmi
for improving EHCD design, precise hemostasis, and EHCD-related collateral injuries.Trial registration Ratification no. 2019092. Registered November 4, 2020-retrospectively registered, www.chictr.org.cn. The transcription factor Tbx5 controls cardiogenesis and drives Scn5a expression in mice. We have identified two variants in TBX5 encoding p.D111Y and p.F206L Tbx5, respectively, in two unrelated patients with structurally normal hearts diagnosed with Long QT (LQTS) and Brugada (BrS) Syndrome. Here we characterized the con
Like
Comment
Share
